Tardive Dyskinesia

Long-Term Effects of Valbenazine Examined in Adults With Tardive Dyskinesia

By November 14, 2017

Maintenance of treatment effect was demonstrated with both doses.

FDA Approves New Dosage Strength for Ingrezza

By October 05, 2017

The 80mg capsule is expected to be available in 30-count bottles within the next two weeks.